The Oak Tree Centre, 1 Oak Drive, Huntingdon, Cambridgeshire, PE29 7HN

Current time is 18:26 - Sorry, we're currently closed. Please call NHS 111

NHS

Telephone: 01480 483100

acorn.enquiries@nhs.net

Research

The Acorn Surgery believes in the power of research and plays an active role in many research studies. The practice is part of a network of General Practices in Cambridgeshire and Peterborough that host medical researches on a regular basis.

We work collaboratively with the NIHR (National Institute for Health Research). Anyone registered within the practice could help to shape the future of health care by helping with research projects that you may be invited to participate in.

There is different levels of patient involvement for every research project. Some may be a single survey, or questionnaire, and some might be taking part in a clinical trial and require interviews. Please consider any patient information leaflets you may receive about the research carefully. If you are interested in finding out more about practice research, please feel free to contact a member of the Acorn Research Team. 

You are completely at liberty to decline any request to take part in a research trial and your full consent will always be obtained before being included in a study.

For even more information on being part of research, visit: https://bepartofresearch.nihr.ac.uk/ 

 

Current Active Research Trials 

INTENSE –  Improving treatment adherence in people with Diabetes Mellitus

The aim of this study is to develop and investigate the effectiveness of a personalised intervention program to improve medication adherence in people with type 2 diabetes, who are non-adherent to oral blood glucose and/or blood pressure lowering medicines. 

There are to groups; one will be an intervention group, receiving a personalised program selected based on their non-adherence profile. The second will receive usual care combined with access to an already available general type 2 diabetes website. 

GLoW – Glucose LOwering through Weight management 

This aims of this research study is to evaluate the effectiveness of different diabetes education programmes. This is for adults that have been diagnosed with type 2 diabetes recently. There is good evidence that people who lose weight, improve their diet, and increase their physical activity can reduce their blood glucose and their risk of developing other health problems, some can even achieve remission from diabetes (which means they have no symptoms or signs of still having diabetes and don’t need to take medication). The trial will evaluate two different programmes to see the best method to advise the NHS to offer for patients. 

PRODEMOS  – Prevention oDementia using Mobile phone Applications

Approximately 1/3 of all dementia cases can be attributed to modifiable risk factors such as leading sedentary lifestyles, being obese, smoking and having hypertension or/and diabetes. The PRODEMOS study is conducting a randomised implementation trial of 2,400 people that are at an increased risk of developing dementia. 1,200 of these will be recruited from the Greater Beijing area of China and a further 1,200 from the UK. This will involve an interactive app on a smartphone. 

PAM – Programme on Adherence to Medication 

The PAM trial is led by our GP practice in collaboration with the University of Cambridge and aims to find effective methods to better support patients with hypertension manage their health condition, by receiving personalised advice about how to take their prescribed medications and improve their health. This involves a supportive text messaging programme or smartphone app. 

PRINCIPLE  – Helping the fight against COVID 

The PRINCIPLE trial is looking at effective treatments to help people presenting with COVID symptoms, particularly those considered ‘at risk’ to see if potential hospitalisation can be prevented and patients can self-manage in primary care and at home. 

VIROLOGY SURVEILLANCE/RSV SURVEILLANCE 

These surveillance studies will include surveillance of swabs taken either within the practice or using a home test kit; with patient knowledge and consent.